PhaseRx, Inc. (PZRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
PhaseRx Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2017 | -18.08 |
| June 30, 2017 | 2.641 |
| March 31, 2017 | 1.051 |
| December 31, 2016 | 0.6134 |
| Date | Value |
|---|---|
| September 30, 2016 | 0.4497 |
| June 30, 2016 | 0.3594 |
| March 31, 2016 | -0.7873 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |